Evidence map›Paper›PMID 37968663›Full record

ReviewItalian journal of pediatrics2023

Use of complementary and alternative medicine in children affected by oncologic, neurologic and liver diseases: a narrative review.

Francesca Casini, Francesca Scaltrito, Maria Teresa Grimaldi, Tudor Lucian Pop, Valeria Calcaterra, Gian Vincenzo Zuccotti, Massimo Pettoello-Mantovani, Pietro Ferrara, Giovanni Corsello, Valentina Fabiano

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Italian journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Francesca CasiniPediatric Department, University of Milan, "V. Buzzi" Children's Hospital, 20154, Milan, Italy.
Francesca ScaltritoDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Maria Teresa GrimaldiDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Tudor Lucian Pop2Nd Pediatric Discipline, Department of Mother and Child, Center of Expertise in Pediatric Liver Rare Diseases, Iuliu Hatieganu University of Medicine and Pharmacy2Nd Pediatric ClinicEmergency Clinical Hospital for Children Cluj-Napoca, Cluj-Napoca, Romania.
Valeria CalcaterraPediatric Department, University of Milan, "V. Buzzi" Children's Hospital, 20154, Milan, Italy.
Gian Vincenzo ZuccottiPediatric Department, University of Milan, "V. Buzzi" Children's Hospital, 20154, Milan, Italy.
Massimo Pettoello-MantovaniDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Pietro FerraraDepartment of Medicine and Surgery, University Campus Bio-Medico, Rome, Italy.
Giovanni CorselloDepartment of Pediatrics, University of Palermo, Palermo, Italy.
Valentina FabianoPediatric Department, University of Milan, "V. Buzzi" Children's Hospital, 20154, Milan, Italy. valentina.fabiano@unimi.it.ORCID http://orcid.org/0000-0001-6449-1724
University of Milan · ITUniversity of Foggia · ITIuliu Hațieganu University of Medicine and Pharmacy · ROUniversità Campus Bio-Medico · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complementary and alternative medicine (CAM) consist of a broad group of restorative resources often linked to existing local cultures and established health care systems and are also increasingly used in children with some serious illnesses. In this narrative review, we examine the epidemiology of the use, efficacy, and safety of complementary and alternative medicine in pediatric oncology, neurology, and hepatology. We searched for relevant articles published in Pubmed evaluating CAM use and its efficacy in safety in children affected by oncologic, neurologic and liver diseases. CAM is used to improve the success of conventional therapies, but also to alleviate the pain, discomfort, and suffering resulting from the diseases and their treatment, which are often associated with a significant burden of adverse effects. CAM use must be evaluated in children with neurological, oncological and liver diseases.

Indexed as

Complementary TherapiesLiver DiseasesNeoplasmsNeurologyChildHumansPainAlternative and complementary medicineChildrenLiver diseasesMedicationsNeurologyOncology

Identifiers

PMID37968663
PMCPMC10647067
OpenAlexW4388700103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.